Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Dec;92(12):1342–1351. doi: 10.1111/j.1349-7006.2001.tb02159.x

A Radicicol Derivative, KF58333, Inhibits Expression of Hypoxia‐inducible Factor‐1α and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts

Junichi Kurebayashi 1,✉, Takemi Otsuki 2,✉, Masafumi Kurosumi 3,✉, Shiro Soga 4,✉, Shiro Akinaga 4,✉, Hiroshi Sonoo 1,✉
PMCID: PMC5926684  PMID: 11749701

Abstract

A novel oxime derivative of radicicol, KF58333, binds to the heat shock protein 90 (Hsp90) and destabilizes its associated signaling molecules. These effects play a critical role in the growth inhibition of tumor cells. To further investigate the effects of this agent, it was administered to two human breast cancer cell lines, KPL‐1 and KPL‐4, both in vitro and in vivo. KF58333 dose‐dependently inhibited the growth and vascular endothelial growth factor (VEGF) secretion, concomitantly with a decrease in VEGF mRNA expression, in each cell line. This agent also suppressed the increase of VEGF secretion and expression induced by hypoxia (1% O2). Intravenous injections of this agent into nude mice bearing either KPL‐1 or KPL‐4 xenografts significantly inhibited the tumor growth associated with a decrease in the Ki67 labeling index and microvascular area and an increase in apoptosis and the necrotic area. These findings indicate that the antitumor activity of this radicicol derivative may be partly mediated by decreasing VEGF secretion from tumor cells and inhibiting tumor angiogenesis. To explore the action mechanisms of the anti‐angiogenic effect, the expression level of hypoxia‐inducible factor (HIF)‐lα was investigated. KF58333 provided a significant decrease in the HTF‐lα protein expression under both normoxic and hypoxic conditions. In contrast, the mRNA expression of HIF‐lα was not decreased by this agent. It is suggested that the post‐transcriptional down‐regulation of HIF‐lα expression by this agent may result in a decrease of VEGF expression and tumor angiogenesis.

Keywords: Radicicol, Hypoxia‐inducible factor‐1, Vascular endothelial growth factor, Breast cancer, Angiogenesis

Full Text

The Full Text of this article is available as a PDF (273.0 KB).

REFERENCES

  • 1. ) Scheibel , T. and Buchner , J.The Hsp90 complex‐a super‐chaperone machine as a novel drug target . Biochem. Pharmacol , 56 , 675 – 682 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Ferrarini , M. , Heltai , S. , Zocchi , M. R. and Rugarli , C.Unusual expression and localization of heat‐shock proteins in human tumor cells . Int. J. Cancer , 51 , 613 – 619 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Whitesell , L. , Mimnaugh , E. G. , De Costa , B. , Myers , C. E. and Neckers , L. M.Inhibition of heat shock protein HSP90‐pp60v‐src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation . Proc. Natl. Acad. Sci. USA , 91 , 8324 – 8328 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Schulte , T. W. , Akinaga , S. , Murakata , T. , Agatsuma , T. , Sugimoto , S. , Nakano , H. , Lee , Y. S. , Simen , B. B. , Argon , Y. , Felts , S. , Toft , D. O. , Neckers , L. M. and Sharma , S. V.Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones . Mol. Endocrinol. , 13 , 1435 – 1448 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Marcu , M. G. , Schulte , T. W. and Neckers , L.Novobiocin and related coumarins and depletion of heat shock protein 90‐dependent signaling proteins . J. Natl. Cancer Inst. , 92 , 242 – 248 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Pearl , L. H. and Prodromou , C.Structure and in vivo function of Hsp90 . Curr. Opin. Struct. Biol. , 10 , 46 – 51 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Kelland , L. R. , Sharp , S. Y. , Rogers , P. M. , Myers , T. G. and Workman , P.DT‐Diaphorase expression and tumor cell sensitivity to 17‐allylamino‐17‐demethoxygeldanamy‐cin, an inhibitor of heat shock protein 90 . J. Natl. Cancer Inst. , 91 , 1940 – 1949 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Soga , S. , Neckers , L. M. , Schulte , T. W. , Shiotsu , Y. , Akasaka , K. , Narumi , H. , Agatsuma , T. , Ikuina , Y. , Murakata , C. , Tamaoki , T. and Akinaga , S.KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules . Cancer Res. , 59 , 2931 – 2938 ( 1999. ). [PubMed] [Google Scholar]
  • 9. ) Shiotsu , Y. , Neckers , L. M. , Wortman , L , An , W. G. , Schulte , T. W. , Soga , S. , Murakata , C. , Tamaoki , T. and Akinaga , S.Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential Gl phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr‐Abl with Hsp90 complex . Blood , 96 , 2284 – 2291 ( 2000. ). [PubMed] [Google Scholar]
  • 10. ) Soga , S. , Sharma , S. V. , Shiotsu , Y. , Shimizu , M. , Tahara , H. , Yamaguchi , K. , Ikuina , Y. , Murakata , C. , Tamaoki , T. , Kurebayashi , J. , Schulte , T. W. , Neckers , L. M. and Akinaga , S.Stereo‐specific antitumor activity of radicicol oxime derivatives . Cancer Chemother. Pharmacol. , 48 , 435 – 445 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Srethapakdi , M. , Liu , F. , Tavorath , R. and Rosen , N.Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product‐dependent Gl arrest . Cancer Res. , 60 , 3940 – 3946 ( 2000. ). [PubMed] [Google Scholar]
  • 12. ) Munster , P. N. , Srethapakdi , M. , Moasser , M. M. and Rosen , N.Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells . Cancer Res. , 61 , 2945 – 2952 ( 2001. ). [PubMed] [Google Scholar]
  • 13. ) Hostein , L , Robertson , D. , DiStefano , F. , Workman , P. and Clarke , P. A.Inhibition of signal transduction by the Hsp90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin results in cytostasis and apoptosis . Cancer Res. , 61 , 4003 – 4009 ( 2001. ). [PubMed] [Google Scholar]
  • 14. ) Folkman , J.Angiogenesis in cancer, vascular, rheumatoid and other disease . Nat. Med. , 1 , 27 – 31 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Kerbel , R. S.Tumor angiogenesis: past, present and the near future . Carcinogenesis , 21 , 505 – 515 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Oikawa , T. , Ito , H. , Ashino , H. , Toi , M. , Tominaga , T. , Morita , I. and Murota , S.Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis . Eur. J. Pharmacol. , 241 , 221 – 227 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Kurebayashi , J. , Kurosumi , M. and Sonoo , H.A new human breast cancer cell line, KPL‐1 secretes tumour‐associated antigens and grows rapidly in female athymic nude mice . Br. J. Cancer , 71 , 845 – 853 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Kurebayashi , J. , Otsuki , T. , Tang , C. K. , Kurosumi , M. , Yamamoto , S. , Tanaka , K. , Mochizuki , M. , Nakamura , H. and Sonoo , H.Isolation and characterization of a new human breast cancer cell line, KPL‐4, expressing the Erb B family receptors and interleukin‐6 . Br. J. Cancer , 79 , 707 – 717 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Richard , D. E. , Berra , E. and Pouyssegur , J.Angiogenesis: how a tumor adapts to hypoxia . Biochem. Biophys. Res. Commun. , 266 , 718 – 722 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Zhong , H. , De Marzo , A. M. , Laughner , E. , Lim , M. , Hilton , D. A. , Zagzag , D. , Buechler , P. , Isaacs , W. B. , Semenza , G. L. and Simons , J. W.Overexpression of hypoxia‐inducible factor 1 alpha in common human cancers and their metastases . Cancer Res. , 59 , 5830 – 5835 ( 1999. ). [PubMed] [Google Scholar]
  • 21. ) Minet , E. , Mottet , D. , Michel , G. , Roland , L , Raes , M. , Remacle , J. and Michiels , C.Hypoxia‐induced activation of HIF‐1: role of HIF‐lalpha‐Hsp90 interaction . FEES Lett. , 460 , 251 – 256 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Kurebayashi , J. , Otsuki , T. , Kunisue , H. , Mikami , Y. , Tanaka , K. , Yamamoto , S. and Sonoo , H.Expression of vascular endothelial growth factor (VEGF) family members in breast cancer . Jpn. J. Cancer Res. , 90 , 977 – 981 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Kurebayashi , J. , Otsuki , T. , Yamamoto , S. , Kurosumi , M. , Nakata , T. , Akinaga , S. and Sonoo , H.A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen‐resistant KPL‐1 human breast cancer cells in vivo but not in vitro . Oncology , 55 ( suppl. 1 ), 23 – 34 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Zacharova , G. and Kubinova , L.Stereological methods based on point counting and unbiased counting frames for two‐dimensional measurements in muscles: comparison with manual and image analysis methods . J. Muscle Res. Cell Motil. , 16 , 295 – 302 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Kurebayashi , J. , Kunisue , H. , Yamamoto , S. , Kurosumi , M. , Otsuki , T. and Sonoo , H.Paradoxical hormone‐responses of KPL‐1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth . Oncology , 59 , 158 – 165 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Kuwashima , Y. , Kobayashi , Y. , Kawarai , A. , Uehara , T. , Kurosumi , M. , Tanuma , J. , Shiromizu , K. , Matsuzawa , M. and Kishi , K.Expression of bcl‐2 and apoptotic DNA fragmentation in human endometrial adenocarcinoma cells . Anticancer Res. , 16 , 3221 – 3224 ( 1996. ). [PubMed] [Google Scholar]
  • 27. ) Kurebayashi , J. , Kurosumi , M. , Isoai , A. , Dickson , R. B. and Sonoo , H.Invasion‐inhibiting factor 2‐albumin conjugate inhibits invasion and spontaneous metastasis of MKL‐4 human breast cancer cells transplanted into female nude mice . Clin. Exp. Metastasis , 14 , 87 – 94 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Otsuki , T. , Yamada , O. , Kurebayashi , J. , Moriya , T. , Sakaguchi , H. , Kunisue , H. , Yata , K. , Uno , M. , Yawata , Y. and Ueki , A.Estrogen receptors in human myeloma cells . Cancer Res. , 60 , 1434 – 1441 ( 2000. ). [PubMed] [Google Scholar]
  • 29. ) Shak , S.Overview of the trastuzumab (Herceptin) anti‐HER2 monoclonal antibody clinical program in HER2‐overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group . Semin. Oncol. , 26 ( suppl. 12 ), 71 – 77 ( 1999. ). [PubMed] [Google Scholar]
  • 30. ) Le , X. F. , Vadlamudi , R. , McWatters , A. , Bae , D. S. , Mills , G. B. , Kumar , R. and Bast , R. C. , Jr.Differential signaling by an anti‐pi 85(HER2) antibody and heregulin . Cancer Res. , 60 , 3522 – 3531 ( 2000. ). [PubMed] [Google Scholar]
  • 31. ) Gibbs , J. B.Mechanism‐based target identification and drug discovery in cancer research . Science , 287 , 1969 – 1973 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Rousseau , S. , Houle , F. , Kotanides , H. , Witte , L. , Waltenberger , J. , Landry , J. and Huot , J.Vascular endothelial growth factor (VEGF)‐driven actin‐based motility is mediated by VEGFR2 and requires concerted activation of stress‐activated protein kinase 2 (SAPK2/p38) and geldana‐mycin‐sensitive phosphorylation of focal adhesion kinase . J. Biol. Chem. , 275 , 10661 – 10672 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Richard , D. E. , Berra , E. , Gothie , E. , Roux , D. and Pouyssegur , J.p42/p44 mitogen‐activated protein kinases phosphorylate hypoxia‐inducible factor 1alpha (HIF‐1alpha) and enhance the transcriptional activity of HIF‐1 . J. Biol. Chem. 274 , 32631 – 32637 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Semenza , G. L.Hypoxia, clonal selection, and the role of HIF‐1 in tumor progression . Crit. Rev. Biochem. Mol. Biol. , 35 , 71 – 103 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Hara , S. , Kobayashi , C. and Imura , N.Molecular cloning of cDNAs encoding hypoxia‐inducible factor (HIF)‐1alpha and ‐2alpha of bovine arterial endothelial cells . Biochim. Biophys. Acta , 1445 , 237 – 243 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Srinivas , V. , Zhang , L. P. , Zhu , X. H. and Caro , J.Characterization of an oxygen/redox‐dependent degradation domain of hypoxia‐inducible factor alpha (HIF‐alpha) proteins . Biochem. Biophys. Res. Commun. , 260 , 557 – 561 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Minet , E. , Michel , G. , Remacle , J. and Michiels , C.Role of HIF‐1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review) . Int. J. Mol. Med. , 5 , 253 – 259 ( 2000. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES